Administrative Core
行政核心
基本信息
- 批准号:10219295
- 负责人:
- 金额:$ 27.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AchievementAdvisory CommitteesAmericanAmerican Heart AssociationAnimalsAreaCenters of Research ExcellenceClinicalCollaborationsCommunicationCore FacilityDiabetes MellitusEndocrinologyEnsureEnvironmentEvaluationFeesFosteringFoundationsFundingGoalsGrantGrowthHealth SciencesHistologyHumanImage AnalysisIncubatedInfrastructureMedicineMentorsOklahomaPaperPeer ReviewPhasePilot ProjectsPlayPreventionProgress ReportsPublished CommentPublishingRegulationResearchResearch PersonnelResearch Project GrantsResource SharingResourcesRoleSamplingScientistSeriesStrategic PlanningUnited States National Institutes of HealthUniversitiesVertebratesWorkcollegedata sharingdiabetichuman subjectimprovedmeetingsmembermicroscopic imagingmid-career facultyoperationprogramsranpirnaserecruitrepositoryresearch facilitysuccesssymposium
项目摘要
PROJECT SUMMARY
Diabetes research is recognized as one of the two strategic areas in the Research Strategic
Plan of The University of Oklahoma Health Sciences Center (OUHSC). The major goal of this
COBRE is to increase the critical mass of diabetes researchers and improve infrastructure for
diabetes research at OUHSC. Our long-term goal is to apply for a NIH P30 Diabetes Research
Center (DRC). In the past nine years of COBRE support, we have closely worked with the Harold
Hamm Diabetes Center and reached our milestones of Phase I and Phase II. The COBRE has
incubated eight NIH R01 grants, two R21s and multiple grants from research foundations such
as the American Diabetes Association and the American Heart Association. The Junior
Investigators supported by the COBRE have published 207 peer-reviewed papers. Five of the
Junior Investigators supported by the COBRE have been promoted to Associate Professors. In
addition, the COBRE has recruited four NIH-funded diabetic researchers into OUHSC. The
Administrative Core has played a central role in leading COBRE operations and contributed to
these achievements. The major goal of this Core in Phase III is to further expand these successes
and assist the research Cores to become sustainable research facilities supported by a
combination of user fees and institutional resources. In Phase III, the Administrative Core will
continue to provide central management of the entire COBRE and coordinate COBRE activities
and interactions among all of the COBRE components. The Administrative Core will also facilitate
interactions of the Diabetes COBRE with other COBREs and research Centers at OUHSC and
throughout the State of Oklahoma. This Core will make an effort to improve the diabetes research
environment and facilitate collaborations in diabetes research. This Core will promote resource
and data sharing strategies and ensure compliance with human subjects, vertebrate animals and
biosafety regulations. This Core will greatly facilitate the continuous growth of the COBRE to
achieve its goals.
项目概要
糖尿病研究被认为是研究战略的两个战略领域之一
俄克拉荷马大学健康科学中心 (OUHSC) 规划。此次活动的主要目标
COBRE 旨在增加糖尿病研究人员的数量并改善糖尿病研究的基础设施
OUHSC 的糖尿病研究。我们的长期目标是申请 NIH P30 糖尿病研究
中心(刚果民主共和国)。在过去九年的 COBRE 支持中,我们与 Harold 密切合作
哈姆糖尿病中心并达到了第一阶段和第二阶段的里程碑。 COBRE 有
孵化了八项 NIH R01 资助、两项 R21 以及来自研究基金会的多项资助,例如
如美国糖尿病协会和美国心脏协会。少年
COBRE 支持的研究人员已发表 207 篇同行评审论文。其中五个
由 COBRE 支持的初级研究员已晋升为副教授。在
此外,COBRE 还招募了四名 NIH 资助的糖尿病研究人员加入 OUHSC。这
行政核心在领导 COBRE 运营方面发挥了核心作用,并为
这些成就。第三阶段该核心的主要目标是进一步扩大这些成功
并协助研究核心成为可持续的研究设施,并得到
使用费和机构资源的结合。在第三阶段,行政核心将
继续对整个 COBRE 进行集中管理并协调 COBRE 活动
以及所有 COBRE 组件之间的交互。行政核心还将促进
糖尿病 COBRE 与 OUHSC 的其他 COBRE 和研究中心的互动以及
整个俄克拉荷马州。该核心将努力改善糖尿病研究
环境并促进糖尿病研究方面的合作。该核心将促进资源
和数据共享策略,并确保符合人类受试者、脊椎动物和
生物安全法规。该核心将极大地促进 COBRE 的持续发展
实现其目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jian-Xing Ma其他文献
Jian-Xing Ma的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jian-Xing Ma', 18)}}的其他基金
Dysregulation of PPARα in RPE degeneration
RPE 变性中 PPARα 的失调
- 批准号:
10736062 - 财政年份:2023
- 资助金额:
$ 27.68万 - 项目类别:
Sustained release of fenofibrate for the treatment of diabetic retinopathy
非诺贝特缓释剂治疗糖尿病视网膜病变
- 批准号:
10684823 - 财政年份:2022
- 资助金额:
$ 27.68万 - 项目类别:
Sustained release of fenofibrate for the treatment of diabetic retinopathy
非诺贝特缓释剂治疗糖尿病视网膜病变
- 批准号:
10521702 - 财政年份:2022
- 资助金额:
$ 27.68万 - 项目类别:
cGAS-STING signaling in diabetic retinopathy
糖尿病视网膜病变中的 cGAS-STING 信号传导
- 批准号:
10610331 - 财政年份:2022
- 资助金额:
$ 27.68万 - 项目类别:
Sustained release of fenofibrate for the treatment of diabetic retinopathy
非诺贝特缓释剂治疗糖尿病视网膜病变
- 批准号:
10684823 - 财政年份:2022
- 资助金额:
$ 27.68万 - 项目类别:
cGAS-STING signaling in diabetic retinopathy
糖尿病视网膜病变中的 cGAS-STING 信号传导
- 批准号:
10339181 - 财政年份:2022
- 资助金额:
$ 27.68万 - 项目类别:
Sustained release of fenofibrate for the treatment of diabetic retinopathy
非诺贝特缓释剂治疗糖尿病视网膜病变
- 批准号:
10521702 - 财政年份:2022
- 资助金额:
$ 27.68万 - 项目类别:
Studies of retinyl ester hydrolase in the visual cycle
视黄酯水解酶在视觉循环中的研究
- 批准号:
10459611 - 财政年份:2021
- 资助金额:
$ 27.68万 - 项目类别:
Studies of retinyl ester hydrolase in the visual cycle
视黄酯水解酶在视觉循环中的研究
- 批准号:
10547900 - 财政年份:2021
- 资助金额:
$ 27.68万 - 项目类别:
Studies of retinyl ester hydrolase in the visual cycle
视黄酯水解酶在视觉循环中的研究
- 批准号:
10652486 - 财政年份:2021
- 资助金额:
$ 27.68万 - 项目类别:
相似海外基金
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
- 批准号:
10557638 - 财政年份:2023
- 资助金额:
$ 27.68万 - 项目类别:
Health Disparities in Utilization, Quality, and Outcomes for Three Common Ocular Conditions (HealthDOC)
三种常见眼部疾病的利用、质量和结果方面的健康差异 (HealthDOC)
- 批准号:
10559239 - 财政年份:2023
- 资助金额:
$ 27.68万 - 项目类别:
Florida Summer Institute for Biostatistics and Data Science
佛罗里达夏季生物统计和数据科学研究所
- 批准号:
10366532 - 财政年份:2022
- 资助金额:
$ 27.68万 - 项目类别:
Optimizing Available Data Sources for Post-Marketing Surveillance: Real-World Use of Left Atrial Appendage Occlusion
优化上市后监测的可用数据源:左心耳封堵术的实际使用
- 批准号:
10701790 - 财政年份:2022
- 资助金额:
$ 27.68万 - 项目类别: